NHS Bath and North East Somerset, Swindon and Wiltshire CCG Royal United Hospitals Bath NHS Foundation Trust Great Western Hospitals NHS Foundation Trust Salisbury NHS Foundation Trust
Please contact the pharmacy department at your trust for local availability of antidotes.
In cases of poisoning it is strongly recommended that advice is sought from NPIS by telephone on 0344 892 0111 or online using Toxbase. Advice is available 24/7/365.
See the current BNF for notes on the emergency treatment of poisoning (click on the BNF icon adjacent to individual drugs for further details).
Details...
18
Poisoning
Acetylcysteine
(Parvolex)
(Paracetamol overdose)
Formulary
Activated charcoal (antidote)
Formulary
Atropine (Antidote)
Formulary
Calcium gluconate gel (antidote)
Formulary
please note, may not be stocked at RUH but can be ordered through supplies
Cyproheptadine
(Periactin®)
Formulary
Ethanol (alcohol) injection (antidote)
Formulary
European Viper Venom Antivenom (antiserum / antidote)
Formulary
Flumazenil (antidote)
Formulary
Fomepizole
Formulary
Hydroxocobalamin
(Cyanokit®)
(antidote)
Formulary
Intralipid
Formulary
Methylthioninium chloride
(Proveblue®)
(methylene blue antidote)
Formulary
Phentolamine (antidote)
Formulary
Procyclidine (Poisoning)
Formulary
Pyridoxine (antidote)
Formulary
Sodium bicarbonate (Poisoning)
Formulary
Sodium nitrite (antidote)
Formulary
Sodium thiosulphate (antidote)
Formulary
please note, may ot be stocked at RUH. Alternatives are stocked
....
Non Formulary Items
Dicobalt edetate (cyanide poisoning)
Non Formulary
discontinued Sept 2019
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
High Cost Drug Approval System
Traffic Light Status Information
Status
Description
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.
